1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Less number of organs donors.
4.1.2. Growth in technological advancement.
4.1.3. Increasing of road accidents which lead to the amputations.
4.2 Restraints & Challenges
4.2.1. High cost
4.2.2. Increasing number of device malfunctions.
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. Global Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. Global Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. Global Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defense
8. Global Artificial Organs and Bionics Market - By Geography
8.1 Introduction
8.2 North America
8.2.1. The U.S.
8.2.2. Canada
8.2.3. Mexico
8.3 South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4 Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Rest of Europe
8.5 Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Rest of APAC
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
9. Global Artificial Organs and Bionics Market - Company Profiles
9.1. Abiomed Inc.
9.2. Asahi Kasei medical co. ltd
9.3. Baxter International Inc.
9.4. Boston Scientific Corporation.
9.5. Berlin Heart GmbH.
9.6. Cochlear limited.
9.7. Cyberonics Inc.
9.8. Edward Lifesciences.
9.9. Ekso Bionic.
9.10. Roche Holding AG
9.11. Medtronic
9.12. Gambro AB.
9.13. Life net health Inc.
9.14. Otto bock healthcare GMBH.
10. Global Artificial Organs and Bionics Market - Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
